Involvement of post‑transcriptional regulation of FOXO1 by HuR in 5‑FU‑induced apoptosis in breast cancer cells

Li,Yunbo; Yu,Jinhai; Du,Danhua; Fu,Shuanglin; Chen,Ye; Yu,Fang; Gao,Peng

doi:10.3892/ol.2013.1352

Involvement of post‑transcriptional regulation of FOXO1 by HuR in 5‑FU‑induced apoptosis in breast cancer cells

Authors:
- Yunbo Li
- Jinhai Yu
- Danhua Du
- Shuanglin Fu
- Ye Chen
- Fang Yu
- Peng Gao
View Affiliations

Affiliations: Norman Bethune College of Medicine, Jilin University, Changchun, Jilin 130041, P.R. China, The First Hospital of Jilin University, Changchun, Jilin 130041, P.R. China, Department of Nutrition and Food Hygiene, Fourth Military Medical University, Xi'an 710032, P.R. China
Published online on: May 17, 2013 https://doi.org/10.3892/ol.2013.1352
Pages: 156-160

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The post‑transcriptional control of specific mRNAs is a widespread mechanism of gene regulation, which contributes to numerous biological processes in a number of cell types. The Forkhead box O (FoxO) transcription factor FOXO1 is an important tumor suppressor involved in apoptosis, the cell cycle, DNA damage repair and oxidative stress. Bioinformatic prediction identified that the 3' untranslated region (UTR) of FOXO1 is enriched with binding motifs for the human ELAV/Hu protein (HuR), indicating that FOXO1 is a potential target of HuR. Luciferase reporter assays demonstrate that HuR specifically regulates FOXO1 expression through AU‑rich elements (AREs) within the FOXO1 3' UTR. Immunoprecipitation studies confirmed that HuR associates with FOXO1 mRNA in MDA‑MB‑231 breast cancer cells and that HuR upregulates FOXO1 mRNA levels through increased mRNA stability. Using a HuR loss‑ and gain‑of‑function approach, we revealed that FOXO1 expression was correspondingly decreased or increased in MDA‑MB‑231 cells. Functional assays demonstrated that HuR and FOXO1 expression levels were markedly enhanced upon 5‑fluorouracil (5‑FU) stimulation in MDA‑MB‑231 cells. Knockdown of HuR apparently abrogated 5‑FU‑induced apoptosis detected by caspase‑3 activities. Furthermore, in HuR knockdown cells, additional overexpression of FOXO1 moderately recovered 5‑FU‑induced apoptosis, which verified that HuR‑modulated apoptosis upon 5‑FU treatment was partially mediated by its post‑transcriptional regulation of FOXO1. Therefore, modulating FOXO1 expression has been suggested to lead to the development of new therapeutic treatments for certain types of cancer.

View Figures

View References

1.	Moore MJ: From birth to death: the complex lives of eukaryotic mRNAs. Science. 309:1514–1518. 2005. View Article : Google Scholar : PubMed/NCBI
2.	Keene JD: RNA regulons: coordination of post-transcriptional events. Nat Rev Genet. 8:533–543. 2007. View Article : Google Scholar : PubMed/NCBI
3.	Brennan CM and Steitz JA: HuR and mRNA stability. Cell Mol Life Sci. 58:266–277. 2001. View Article : Google Scholar : PubMed/NCBI
4.	Gorospe M: HuR in the mammalian genotoxic response: post-transcriptional multitasking. Cell Cycle. 2:412–414. 2003. View Article : Google Scholar : PubMed/NCBI
5.	Fan XC and Steitz JA: Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17:3448–3460. 1998. View Article : Google Scholar : PubMed/NCBI
6.	Blackshear PJ: Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem Soc Trans. 30:945–952. 2002. View Article : Google Scholar : PubMed/NCBI
7.	Heinonen M, Bono P, Narko K, et al: Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res. 65:2157–2161. 2005. View Article : Google Scholar : PubMed/NCBI
8.	Wang W, Furneaux H, Cheng H, et al: HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol. 20:760–769. 2000. View Article : Google Scholar : PubMed/NCBI
9.	Zou T, Mazan-Mamczarz K, Rao JN, et al: Polyamine depletion increases cytoplasmic levels of RNA-binding protein HuR leading to stabilization of nucleophosmin and p53 mRNAs. J Biol Chem. 281:19387–19394. 2006. View Article : Google Scholar : PubMed/NCBI
10.	Erkinheimo TL, Lassus H, Sivula A, et al: Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res. 63:7591–7594. 2003.PubMed/NCBI
11.	Arden KC: Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp Gerontol. 41:709–717. 2006. View Article : Google Scholar : PubMed/NCBI
12.	Birkenkamp KU and Coffer PJ: Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans. 31:292–297. 2003. View Article : Google Scholar : PubMed/NCBI
13.	Paik JH, Kollipara R, Chu G, et al: FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 128:309–323. 2007. View Article : Google Scholar : PubMed/NCBI
14.	Adachi M, Osawa Y, Uchinami H, Kitamura T, Accili D and Brenner DA: The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells. Gastroenterology. 132:1434–1446. 2007. View Article : Google Scholar : PubMed/NCBI
15.	Finlay D, Patel S, Dickson LM, et al: Glycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response element. BMC Mol Biol. 5:152004. View Article : Google Scholar : PubMed/NCBI
16.	Roy SK, Srivastava RK and Shankar S: Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. J Mol Signal. 5:102010. View Article : Google Scholar : PubMed/NCBI
17.	Potente M, Fisslthaler B, Busse R and Fleming I: 11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1. J Biol Chem. 278:29619–29625. 2003. View Article : Google Scholar : PubMed/NCBI
18.	Sengupta A, Molkentin JD, Paik JH, DePinho RA and Yutzey KE: FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress. J Biol Chem. 286:7468–7478. 2011. View Article : Google Scholar : PubMed/NCBI
19.	Tang H, Lee M, Budak MT, et al: Intrinsic apoptosis in mechanically ventilated human diaphragm: linkage to a novel Fos/FoxO1/Stat3-Bim axis. FASEB J. 25:2921–2936. 2011. View Article : Google Scholar : PubMed/NCBI
20.	Raghavendra PB, Pathak N and Manna SK: Novel role of thiadiazolidine derivatives in inducing cell death through Myc-Max, Akt, FKHR, and FasL pathway. Biochem Pharmacol. 78:495–503. 2009. View Article : Google Scholar : PubMed/NCBI
21.	Tran H, Brunet A, Griffith EC and Greenberg ME: The many forks in FOXO’s road. Sci STKE: RE5. 2003.
22.	Nakae J, Biggs WH 3rd, Kitamura T, et al: Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet. 32:245–253. 2002. View Article : Google Scholar : PubMed/NCBI
23.	Liu P, Kao TP and Huang H: CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor. Oncogene. 27:4733–4744. 2008. View Article : Google Scholar : PubMed/NCBI
24.	Wu Y, Shang X, Sarkissyan M, Slamon D and Vadgama JV: FOXO1A is a target for HER2-overexpressing breast tumors. Cancer Res. 70:5475–5485. 2010. View Article : Google Scholar : PubMed/NCBI
25.	Abdelnour-Berchtold E, Cerantola Y, Roulin D, Dormond-Meuwly A, Demartines N and Dormond O: Rapamycin-mediated FOXO1 inactivation reduces the anticancer efficacy of rapamycin. Anticancer Res. 30:799–804. 2010.PubMed/NCBI
26.	Zhang H, Pan Y, Zheng L, et al: FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer Res. 71:3257–3267. 2011. View Article : Google Scholar : PubMed/NCBI